EUVIMEDEUVIMED entdecken
Crossref

US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma

Edward R Scheffer Cliff iD, David A Russler-Germain iD, C Joseph Ross Daval, Aaron S Kesselheim iD

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.24.00100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Edward R Scheffer Cliff und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hos…. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Aminopterin, Lymphoma, T-Cell, Sulfonamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The FDA's directive to deal with delayed confirmatory trials: lessons from pralatrexate and belinostat for T-cell lymphoma

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

United States Food and Drug AdministrationAminopterinLymphoma, T-CellSulfonamidesHydroxamic AcidsHumansUnited StatesClinical Trials as TopicDrug ApprovalFolic Acid Antagonists

Substanzen

10-propargyl-10-deazaaminopterinAminopterinbelinostatSulfonamidesHydroxamic AcidsFolic Acid Antagonists

Autor:innen und Institutionen

  • Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
  • Harvard Medical School, Boston, MA.
  • Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.
  • Siteman Cancer Center, St Louis, MO.

ORCID-Profile: Edward R Scheffer Cliff, David A Russler-Germain, Aaron S Kesselheim

Zitieren

APA

Cliff, E. R. S., Russler-Germain, D. A., Daval, C. J. R., & Kesselheim, A. S. (2024). US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00100

Vancouver

Cliff ERS, Russler-Germain DA, Daval CJR, Kesselheim AS. US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma. Journal of Clinical Oncology. 2024. doi:10.1200/jco.24.00100

BibTeX
@article{Cliff2024,
  author = {Cliff, Edward R Scheffer and Russler-Germain, David A and Daval, C Joseph Ross and Kesselheim, Aaron S},
  title = {US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.24.00100}
}
Kostenlos starten →